Delcath Systems (DCTH) Reports Q3 Loss of $0.12/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Delcath Reports 2015 Third Quarter Financial Results
November 10, 2015 8:30 AM ESTNEW YORK, Nov. 10, 2015 /PRNewswire/ --Â Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces financial results for the three and nine months ended September 30, 2015.Â
Financial and other highlights for the third quarter of 2015 and recent weeks included:
84% increase in total revenue compared with the third quarter of 2014 23% decrease in total operating expenses compared with the third quarter of 2014 Establishment of national reimbursement coverage for CHEMOSAT®... More